Twinbeech Capital LP Pulmonx Corp Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$7.89 - $13.14 $101,615 - $169,230
-12,879 Reduced 39.21%
19,966 $254,000
Q3 2023

Nov 14, 2023
BUY
$9.88 - $14.0 $5,898 - $8,358
597 Added 1.85%
32,845 $339,000
Q2 2023

Aug 14, 2023
BUY
$10.78 - $13.65 $347,633 - $440,185
32,248 New
32,248 $422,000
Q3 2022

Nov 14, 2022
BUY
$15.35 - $23.99 $770,170 - $1.2 Million
50,174 New
50,174 $836,000

Others Institutions Holding LUNG

# of Institutions
123
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email